A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investiga
Avril Tierney is one of many women benefitting from breakthrough personalised treatments for advanced breast cancer which has led to a dramatic increase in survival ratesĀ
COLAISTE Lorcáin, Castledermot held its transition-year graduation ceremony just before school finished for the academic year. A large gathering of parents and…